Thursday, June 1, 2023

Venus Remedies gets marketing authorization from Saudi Arabia for chemotherapy drug Docetaxel

Venus Remedies gets marketing authorization from Saudi Arabia for chemotherapy drug Docetaxel The development comes three months after the company received good manufacturing practices (GMP) certification from the Saudi Food and Drug Authority (SFDA) for all its production facilities at its unit in Baddi, Himachal Pradesh.

from Moneycontrol Business News https://ift.tt/85H3Aib

No comments:

Post a Comment

LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally

A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...